Evidence map›Paper›PMID 38740932›Full record

ArticleNature microbiology2024

Propionate prevents loss of the PDIM virulence lipid in Mycobacterium tuberculosis.

Claire V Mulholland, Thomas J Wiggins, Jinhua Cui, Catherine Vilchèze, Saranathan Rajagopalan, Michael W Shultis, Esmeralda Z Reyes-Fernández, William R Jacobs, Michael Berney

Abstract read
In one paragraph

Article in Nature microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Protein kinase F regulates the virulence ofInfection and immunity · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Modulation of Ferroptosis During EarlybioRxiv : the preprint server for biology · 2026
    Article
  11. A new Persister Enrichment Model inbioRxiv : the preprint server for biology · 2026
    Article
  12. Article
  13. Article
  14. Review
  15. Tyloxapol inhibits ESX-1 secretion inJournal of bacteriology · 2026
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Claire V MulhollandDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, New York, NY, USA.ORCID http://orcid.org/0000-0002-6156-1798
Thomas J Wiggins *Department of Microbiology and Immunology, Albert Einstein College of Medicine, New York, NY, USA.
Jinhua Cui *Department of Microbiology and Immunology, Albert Einstein College of Medicine, New York, NY, USA.
Catherine VilchèzeDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, New York, NY, USA.
Saranathan RajagopalanDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, New York, NY, USA.
Michael W ShultisDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, New York, NY, USA.
Esmeralda Z Reyes-FernándezDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, New York, NY, USA.
William R JacobsDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, New York, NY, USA.ORCID http://orcid.org/0000-0003-3321-3080
Michael BerneyDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, New York, NY, USA. michael.berney@einsteinmed.edu.ORCID http://orcid.org/0000-0002-4833-0573

Funding

Molecular Genetic Analysis of Mycobacterium TuberculosisR37AI026170 · NIAID · ALBERT EINSTEIN COL OF MED YESHIVA UNIV · PI WILLIAM Robert JACOBS · 2004 to 2026
$7.7M
Medical Scientist Training ProgramT32GM149364 · NIGMS · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI Myles H. Akabas · 2023 to 2026
$7.5M
MOLECULAR GENETIC ANALYSIS OF MYCOBACTERIUM TUBERCULOSISR01AI026170 · NIAID · YESHIVA UNIVERSITY · PI JACOBS, WILLIAM ROBERT · 1989 to 2022
$7.1M
Training in HIV/AIDS Pathogenesis; Basic and Translational ResearchT32AI007501 · NIAID · YESHIVA UNIVERSITY · PI PRASAD, VINAYAKA R. · 1995 to 2024
$6.6M
Generation of a Complete Set of Precise Null Bar-Coded Deletion Mutants of Mycobacterium tuberculosisR24AI134650 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI Shazia Hamid, WILLIAM Robert JACOBS · 2017 to 2026
$5.6M
Eradicating persistent M. tuberculosis by synthetic lethality of terminal respiratory oxidasesR01AI139465 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI BERNEY, MICHAEL · 2019 to 2023
$3.2M
Identification of new inhibitors of essential functions in M. tuberculosis by high-throughput metabolic profilingR01AI173328 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI Michael Berney · 2023 to 2026
$2.6M
The PDIM paradox of M. tuberculosisR01AI175972 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI Michael Berney · 2023 to 2026
$2.0M
NIAID NIH HHS R01 AI026170NIAID NIH HHS R01 AI139465NIAID NIH HHS R01 AI173328NIAID NIH HHS R01 AI175972NIAID NIH HHS R24 AI134650NIAID NIH HHS R37 AI026170NIAID NIH HHS T32 AI007501NIGMS NIH HHS T32 GM149364
6 · The paper itself

Abstract

Phthiocerol dimycocerosate (PDIM) is an essential virulence lipid of Mycobacterium tuberculosis. In vitro culturing rapidly selects for spontaneous PDIM-negative mutants that have attenuated virulence and increased cell wall permeability, thus impacting the relevance of experimental findings. PDIM loss can also reduce the efficacy of the BCG Pasteur vaccine. Here we show that vancomycin susceptibility can rapidly screen for M. tuberculosis PDIM production. We find that metabolic deficiency of methylmalonyl-CoA impedes the growth of PDIM-producing bacilli, selecting for PDIM-negative variants. Supplementation with odd-chain fatty acids, cholesterol or vitamin B

Indexed as

Mycobacterium tuberculosisPropionatesAcyl Coenzyme ACholesterolCholesterol EstersFatty AcidsHumansLipidsMutationTuberculosisVirulenceVirulence FactorsVitamin B 12Acyl Coenzyme ACholesterolCholesterol EstersFatty AcidsLipidsmethylmalonyl-coenzyme Aphthiocerol dimycocerosatePropionatesVirulence FactorsVitamin B 12

Identifiers

PMID38740932
PMCPMC11253637

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.